L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating

The L&G Gerd Kommer Multifactor Equity UCITS ETF is frequently paired with broad market global equity trackers like SPYI, which accounts for 43 percent of the Altersvorsorge Scalabel portfolio. Other investors integrate GERD into more complex, multi-asset structures alongside regional equity funds such as PABZ and 2B7K, or even commodities like SXRS. These combinations suggest a strategy of using GERD as a core multifactor engine to capture specific risk premia, while using broad market or commodity assets to dampen volatility and provide a hedge against the concentrated factor exposure inherent in a pure multifactor approach.

Community members generally treat GERD as a high-conviction, standalone investment or a dominant core holding. While some users maintain 100 percent allocations to the fund to capture its pure multifactor strategy, others blend it with broad market trackers to balance risk, as seen in the 57 percent GERD and 43 percent SPYI split. The data shows that while GERD is capable of delivering robust returns near 17.5 percent annually, its inclusion in more conservative, diversified portfolios remains minimal, indicating that users view it primarily as an aggressive growth tool rather than a defensive component for lower-volatility portfolios.